Product Program year 2020 Source: CMS Open Payments

Altis

Device Female Incontinence

Open in the dashboard

General payments

$1,508,851

5,256 payments

Research payments

$363,862

126 payments

Through program year 2020, $1,508,851 in general payments and $363,862 in research payments were reported against Altis (Female Incontinence).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $403,850 1,070
2020 Research $94,729 37
2019 General $1,105,000 4,186
2019 Research $269,132 89

Breakdown

Who paid General payments · program years 2019–2020
  1. Coloplast Corp $1,508,851 5,256 payments
Top recipients General payments · program year 2020
  1. Costas Apostolis Urogynecology and Reconstructive Pelvic Surgery · Strongsville, OH $61,166 15% · 27 payments
  2. Loyola University Medical Center Teaching hospital · IL $40,000 10% · 1 payment
  3. James Lukban Obstetrics & Gynecology · Englewood, CO $28,597 7% · 11 payments
  4. Vincent Lucente Urogynecology and Reconstructive Pelvic Surgery · Allentown, PA $25,955 6% · 20 payments
  5. Emily Cole Urology · San Diego, CA $23,780 6% · 26 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Urogynecology and Reconstructive Pelvic Surgery Obstetrics & Gynecology $173,219 48% · 90 practitioners
  2. Urology $91,868 25% · 180 practitioners
  3. Obstetrics & Gynecology $77,373 21% · 177 practitioners
  4. Urogynecology and Reconstructive Pelvic Surgery Urology $12,231 3% · 18 practitioners
  5. Gynecology Obstetrics & Gynecology $5,921 2% · 27 practitioners

The top 5 of 13 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Ohio $64,457 16% · 11 recipients
  2. California $46,009 11% · 53 recipients
  3. Illinois $40,530 10% · 5 recipients
  4. Texas $35,397 9% · 67 recipients
  5. Colorado $33,383 8% · 10 recipients

The top 5 of 38 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

5,256 general · 126 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record